Which drug is recommended for prevention of mother to child transmission of HIV infection?’
**Core Concept**: Prevention of mother-to-child transmission (PMTCT) of Human Immunodeficiency Virus (HIV) is a crucial aspect of HIV management, particularly in resource-limited settings. Antiretroviral therapy (ART) plays a significant role in reducing the risk of transmission.
**Why the Correct Answer is Right**: In this scenario, the correct answer is referring to the use of zidovudine (AZT) as part of a combination antiretroviral therapy (cART). Zidovudine is an antiretroviral drug that works by inhibiting reverse transcriptase, a key enzyme in the HIV replication process. By inhibiting reverse transcriptase, zidovudine helps to reduce viral load in the mother and decrease the risk of transmission to the child during pregnancy, childbirth, and breastfeeding.
**Why Each Wrong Option is Incorrect**:
A. AZT is not the only drug recommended for PMTCT. However, since the question focuses on the correct answer, we address the incorrect options briefly:
1. Option A (empirical treatment) is not specific to PMTCT and does not address the mode of transmission effectively.
2. Option B (single drug therapy) is not effective in reducing the risk of transmission, as it lacks the synergistic effect of multiple drugs in combination.
3. Option C (non-ART) does not provide antiretroviral protection, making it inadequate for PMTCT.
D. AZT is one component of a combination antiretroviral therapy (cART), which is highly effective in reducing the risk of mother-to-child transmission.
**Clinical Pearl**: Combination antiretroviral therapy (cART) is the standard of care for PMTCT, not just a single drug like AZT. The World Health Organization (WHO) recommends a three-drug regimen, including an NRTI (nucleoside/nucleotide reverse transcriptase inhibitor) like AZT, an NNRTI (non-nucleoside/nucleotide reverse transcriptase inhibitor), and an INSTI (integrase strand-transcriptase inhibitor). This combination provides a higher success rate in preventing mother-to-child transmission and is usually prescribed as part of a comprehensive PMTCT program.